[Drug turnover in the Russian Federation: customs aspect]

Area of Science:

• Pharmaceutical Market Analysis
• Health Economics
• International Trade Law

Background:

• The Russian pharmaceutical industry is strategically critical, necessitating reduced reliance on imported medical goods.
• Complete import substitution is not feasible, highlighting the importance of global collaboration and experience exchange.
• Globalization and current geopolitical factors underscore the relevance of international pharmaceutical trade.

Purpose of the Study:

• To analyze the current state, potential, and development trends of the Russian pharmaceutical market.
• To examine the significance of reducing import dependence in the medical industry.
• To assess the implications of international trade and customs legislation on medicine import within the Eurasian Economic Union (EEU).

Main Methods:

• Analysis of the Russian pharmaceutical market's current status and developmental trajectories.
• Review of legislative frameworks governing the import of medicines into the EEU.
• Examination of customs procedures and compliance requirements for pharmaceutical products.

Main Results:

• The Russian pharmaceutical market requires strategic development to balance import reduction with international cooperation.
• Full import substitution is unachievable, emphasizing the need for regulated international exchange of medicines.
• Compliance with EEU customs legislation is fundamental for the import of pharmaceutical goods.

Conclusions:

• Strategic development of the Russian pharmaceutical sector must balance self-sufficiency with global engagement.
• Effective navigation of customs regulations is essential for the successful import of medicines into the EEU.
• The study underscores the dynamic interplay between national pharmaceutical strategies and international trade dynamics.